PARP1 and central nervous system cancer: Inhibition of PARP1 restores GSCs sensitivity to TMZ,233 enhances glioma‐initiating cell sensitivity to radiation, and inhibits glioma‐initiating cell growth, self‐renewal, and DNA damage repair.